Huddinge, Sweden

Carl Erik Daniel Jönsson



Average Co-Inventor Count = 9.6

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2010-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Innovations of Carl Erik Daniel Jönsson: A Pioneer in HCV Inhibition**

Introduction

Carl Erik Daniel Jönsson is a distinguished inventor based in Huddinge, Sweden. With a remarkable contribution to medical science, he holds two patents focused on hepatitis C virus (HCV) inhibitors. His innovative work has implications for the development of new therapeutic agents that could significantly impact the treatment of HCV.

Latest Patents

Jönsson’s latest patents include groundbreaking formulations such as "HCV inhibiting macrocyclic phenylcarbamates" and "Macrocyclic inhibitors of hepatitis C virus." These patented compounds are characterized by their formula I, which encompasses various stereoisomers, N-oxides, and pharmaceutically acceptable salts or solvates. His inventions aim to provide effective HCV inhibitors and outlines processes for synthesizing these compounds along with pharmaceutical compositions that utilize them as active ingredients.

Career Highlights

Throughout his career, Jönsson has made significant strides in the pharmaceutical industry. He has been associated with notable companies such as Tibotec Pharmaceuticals Ltd. and Medivir AB, where he has played a crucial role in advancing innovative solutions for HCV treatment. His experience and expertise in the field demonstrate his commitment to fostering medical advancements through relentless research and development.

Collaborations

Collaborating with other talented scientists has been an essential aspect of Jönsson's work. He has worked alongside distinguished colleagues such as Pierre Jean-Marie Bernard Raboisson and Karl Magnus Nilsson. These collaborations have enabled him to expand the horizons of his research and contribute to innovative solutions in combating viral infections.

Conclusion

Carl Erik Daniel Jönsson stands out as a pioneering inventor in the realm of hepatitis C virus research. His patents signify important advancements that could lead to better therapeutic options for patients affected by HCV. With a strong track record in the pharmaceutical industry and valuable collaborations, Jönsson continues to be an influential figure in the fight against viral diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…